Advertisement

Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol

  • P. B. ClarkEmail author
  • H. D. Gage
  • C. Brown-Proctor
  • N. Buchheimer
  • J. Calles-Escandon
  • R. H. Mach
  • K. A. Morton
Short Communication

Abstract

The pancreas is one of the most heavily innervated peripheral organs in the body. Parasympathetic and sympathetic neurons terminate in the pancreas and provide tight control of endocrine and exocrine functions. The aim of this study was to determine whether the pancreas can be imaged with a radioligand that binds to specific neuroreceptors. Using fluorine-18 4-fluorobenzyltrozamicol (FBT), which binds to the presynaptic vesicular acetylcholine transporter, positron emission tomography scans were performed in four adult mice, two adult rhesus monkeys, and one adult human. In these mammals, the pancreas is intensely FBT avid, with uptake greater than in any other organ at 30, 60, and 90 min. The maximum standardized uptake value (SUV) ratios of pancreas to liver, for example, ranged from 1.4 to 1.7 in rhesus monkeys (mean 1.6; median 1.7) and from 1.9 to 4.7 (mean 3.24; median 3.02) in mice. The maximum SUV ratio of pancreas to liver in the human was 1.8. These data suggest that neuroreceptor imaging of the pancreas in vivo is feasible in animal models and humans. This imaging could allow researchers to interrogate functions under control of the autonomic nervous system in the pancreas, with applications possible in transplanted and native pancreata. Also, as beta cell function is intimately related to parasympathetic cholinergic input, FBT activity in the pancreas may correlate with insulin-producing beta cell mass. This could ultimately provide a method of in vivo imaging in animal models and humans for diabetes research.

Keywords

Positron emission tomography Pancreas Beta cell Parasympathetic Vesicular acetylcholine transporter 

References

  1. 1.
    Efange SMN, Mach RH, Khare A, Michelson RH, Nowak PA, Evora PH. p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition—reconstitution approach to vesamicol receptor radioligands for positron emission tomography. Appl Radiat Isot 1994; 45:465–472.CrossRefPubMedGoogle Scholar
  2. 2.
    Voytko ML, Mach RH, Gage HD, Ehrenkaufer RL, Efange SM, Tobin JR. Cholinergic activity of aged rhesus monkeys revealed by positron emission tomography. Synapse 2001; 39:95–100.CrossRefPubMedGoogle Scholar
  3. 3.
    Mach RH, Voytko ML, Ehrenkaufer RL, Nader MA, Tobin JR, Efange SM, Parsons SM, Gage HD, Smith CR, Morton TE. Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates. Synapse 1997; 25:368–380.CrossRefPubMedGoogle Scholar
  4. 4.
    Gilon P, Henquin J-C. Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 2001; 22:565–604.PubMedGoogle Scholar
  5. 5.
    Ahrén B. Autonomic regulation of islet hormone secretion—implications for health and disease. Diabetologia 2000; 43:393–410.Google Scholar
  6. 6.
    Godfrey DA, Matschinsky FM. Enzymes of the cholinergic system in islets of Langerhans. J Histochem Cytochem 1975; 23:645–651.PubMedGoogle Scholar
  7. 7.
    Komabayashi T, Sawada H, Izawa T, Kogo H. Altered intracellular Ca2+ regulation in pancreatic acinar cells from acute streptozotocin-induced diabetic rats. Eur J Pharmacol 1996; 298:299–306.CrossRefPubMedGoogle Scholar
  8. 8.
    Ostenson CG, Grill V. Evidence that hyperglycemia increases muscarinic binding in pancreatic islets of the rat. Endocrinology 1987; 121:1705–1710.PubMedGoogle Scholar
  9. 9.
    Liang Y, Jetton TL, Lubkin M, Meier AH, Cincotta AH. Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse. Cell Mol Life Sci 1998; 54:703–711.CrossRefPubMedGoogle Scholar
  10. 10.
    Adeghate E. Pancreatic tissue grafts are reinnervated by neuro-peptidergic and cholinergic nerves within five days of transplantation. Transpl Immunol 2003; 10:73–80.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • P. B. Clark
    • 1
    Email author
  • H. D. Gage
    • 1
  • C. Brown-Proctor
    • 1
  • N. Buchheimer
    • 1
  • J. Calles-Escandon
    • 2
  • R. H. Mach
    • 3
  • K. A. Morton
    • 1
  1. 1.Nuclear Medicine Section, Department of RadiologyWake Forest University School of MedicineWinston-SalemUSA
  2. 2.Department of Internal MedicineWake Forest University School of MedicineWinston-SalemUSA
  3. 3.Mallinckrodt Institute of RadiologyWashington University School of MedicineSt. LouisUSA

Personalised recommendations